Categories: Appointment

Kilitch Drugs Announces Appointment of New Members to the Board

Mumbai, July 27, 2018: The Board of Directors of Kilitch Drugs Ltd(BSE Code: 524500& NSE: Kilitch) announced the appointmentof Mr. V.S. Rajan and Prof.V.K Murti as Independent Non-executive Directors.

Mr.  Mukund P Mehta, Managing Director,Kilitch Drugs Ltd said, “We welcome Mr. Rajan and Prof.Murti to the Board. Both bring rich experience in the field of pharmaceuticals and organisational development. Their support and guidance will be of great value as Kilitch prepares to chart a new growth agenda.”

V.S. Rajan has been in executive roles with companies such as Pfizer India, Warner Hindustan, Anamed Instruments, among others. He holds a Business Management Degree and a Masters in Marketing.

Prof. V K Murti is an adviser to many owner managed companies and is also on the Board of Gem & Jewellery Skill Council of India. He is a faculty member at S P Jain Institute of Management & Research.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

8 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago